KALA BIO, Inc. (KALA) Signs LOI to Buy Telehealth MSO for ~$15M

KALA BIO, Inc. signed a non-binding LOI to acquire a 50-state telehealth MSO for approximately $15M, funded with cash and stock. The Target reported unaudited TTM revenue of ~$12.7M and ~$48M sales since 2023; closing is targeted for late 2026 or early 2027, subject to diligence.Material DetailsCon…